These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27259460)

  • 21. A comparison of change point models with application to longitudinal lung function measurements in children with cystic fibrosis.
    Moss A; Juarez-Colunga E; Nathoo F; Wagner B; Sagel S
    Stat Med; 2016 May; 35(12):2058-73. PubMed ID: 27118629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of allergic bronchopulmonary aspergillosis on FEV
    Kaditis AG; Miligkos M; Bossi A; Colombo C; Hatziagorou E; Kashirskaya N; de Monestrol I; Thomas M; Mei-Zahav M; Chrousos G; Zolin A
    Arch Dis Child; 2017 Aug; 102(8):742-747. PubMed ID: 28325727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis.
    Judge EP; Dodd JD; Masterson JB; Gallagher CG
    Chest; 2006 Nov; 130(5):1424-32. PubMed ID: 17099020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral.
    Rosenbluth DB; Wilson K; Ferkol T; Schuster DP
    Chest; 2004 Aug; 126(2):412-9. PubMed ID: 15302726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variations in toll-like receptor pathway and lung function decline in Cystic fibrosis patients.
    Haerynck F; Mahachie John JM; Van Steen K; Schelstraete P; Van daele S; Loeys B; Van Thielen M; De Canck I; Nuytinck L; De Baets F
    Hum Immunol; 2013 Dec; 74(12):1649-55. PubMed ID: 23994582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis.
    Amadori A; Antonelli A; Balteri I; Schreiber A; Bugiani M; De Rose V
    Respir Med; 2009 Mar; 103(3):407-13. PubMed ID: 19027279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between FEV1 and peak oxygen uptake in children with cystic fibrosis.
    Pianosi P; LeBlanc J; Almudevar A
    Pediatr Pulmonol; 2005 Oct; 40(4):324-9. PubMed ID: 16082708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study.
    Taylor-Robinson D; Whitehead M; Diderichsen F; Olesen HV; Pressler T; Smyth RL; Diggle P
    Thorax; 2012 Oct; 67(10):860-6. PubMed ID: 22555277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors and outcome of low initial forced expiratory volume in 1 second measurement in children with cystic fibrosis.
    Com G; Carroll JL; Castro MM; Tang X; Jambhekar S; Berlinski A
    J Pediatr; 2014 Apr; 164(4):832-8. PubMed ID: 24418473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving rate of decline of FEV1 in young adults with cystic fibrosis.
    Que C; Cullinan P; Geddes D
    Thorax; 2006 Feb; 61(2):155-7. PubMed ID: 16384880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for progression of structural lung disease in school-age children with cystic fibrosis.
    Svedberg M; Gustafsson P; Tiddens H; Imberg H; Pivodic A; Lindblad A
    J Cyst Fibros; 2020 Nov; 19(6):910-916. PubMed ID: 31672554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.
    Dasenbrook EC; Merlo CA; Diener-West M; Lechtzin N; Boyle MP
    Am J Respir Crit Care Med; 2008 Oct; 178(8):814-21. PubMed ID: 18669817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with reduced FEV1 in adult patients with cystic fibrosis in a relatively affluent area.
    Jarad NA; Higgs S; Jeffcote T; Giles K
    Chron Respir Dis; 2005; 2(3):133-7. PubMed ID: 16281436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of Antibiotic Treatment to Recovery after Acute FEV
    Morgan WJ; Wagener JS; Pasta DJ; Millar SJ; VanDevanter DR; Konstan MW;
    Ann Am Thorac Soc; 2017 Jun; 14(6):937-942. PubMed ID: 28324670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis.
    Gustafsson PM; De Jong PA; Tiddens HA; Lindblad A
    Thorax; 2008 Feb; 63(2):129-34. PubMed ID: 17675316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection, inflammation, and lung function decline in infants with cystic fibrosis.
    Pillarisetti N; Williamson E; Linnane B; Skoric B; Robertson CF; Robinson P; Massie J; Hall GL; Sly P; Stick S; Ranganathan S;
    Am J Respir Crit Care Med; 2011 Jul; 184(1):75-81. PubMed ID: 21493738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiopulmonary exercise testing in children with cystic fibrosis: one centre's experience.
    Weir E; Burns PD; Devenny A; Young D; Paton JY
    Arch Dis Child; 2017 May; 102(5):440-444. PubMed ID: 27919886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis.
    Sanders DB; Emerson J; Ren CL; Schechter MS; Gibson RL; Morgan W; Rosenfeld M;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1170-6. PubMed ID: 26288390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of chronic Candida albicans respiratory infection with a more severe lung disease in patients with cystic fibrosis.
    Gileles-Hillel A; Shoseyov D; Polacheck I; Korem M; Kerem E; Cohen-Cymberknoh M
    Pediatr Pulmonol; 2015 Nov; 50(11):1082-9. PubMed ID: 26383963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.
    Waters V; Stanojevic S; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
    Eur Respir J; 2012 Jul; 40(1):61-6. PubMed ID: 22135280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.